Disulfiram 500 MG Oral Tablet — RxCUI 197624
RxNorm drug concept · Semantic clinical drug
RxCUI 197624
Semantic clinical drug · SCD
● Current RxNorm concept 4 FDA products
6 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197624
Official nameDisulfiram 500 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped6
Reported Medicaid activity (SDUD)3,966 prescriptions · 30 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Disulfiram: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Disulfiram doesn't reduce cravings the way some other medications do. Instead, it changes how your body handles alcohol — if you drink while taking it, you'll experience a really u...
- What exactly does disulfiram do, and why would my doctor prescribe it?
- That depends entirely on your recovery progress. Some people take disulfiram for months; others need it for a year or more. Your doctor will work with you to figure out when you've...
- Unfortunately, yes — even hidden alcohol can trigger the reaction. That includes cooking sauces, vinegar, certain cough medicines, mouthwash, and even some aftershave lotions or ba...
🕸️ Concept Web — How Disulfiram 500 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Disulfiram 500 MG Oral Tablet
RxCUI 197624 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Disulfiram
3554IN
-
Disulfiram
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Antabuse
151358BN
-
Antabuse
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Disulfiram Oral Tablet
371940SCDF -
Disulfiram Oral Product
1159602SCDG -
Disulfiram Pill
1159603SCDG -
Disulfiram Oral Tablet [Antabuse]
367893SBDF -
Antabuse Oral Product
1176831SBDG -
Antabuse Pill
1176832SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Disulfiram Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Disulfiram 500 MG
315842SCDC -
Disulfiram 500 MG Oral Tablet [Antabuse]
210716SBD -
Disulfiram 500 MG [Antabuse]
571203SBDC
-
Disulfiram 500 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Disulfiram 500 MG
SCDC · 315842 -
Disulfiram Oral Tablet
SCDF · 371940 -
Disulfiram Oral Product
SCDG · 1159602 -
Disulfiram Pill
SCDG · 1159603
Brand-Name Concepts
-
Disulfiram 500 MG Oral Tablet [Antabuse]
SBD · 210716 -
Disulfiram 500 MG [Antabuse]
SBDC · 571203 -
Disulfiram Oral Tablet [Antabuse]
SBDF · 367893 -
Antabuse Oral Product
SBDG · 1176831 -
Antabuse Pill
SBDG · 1176832 -
Antabuse
BN · 151358
📦 FDA Products & Package NDCs
4 products · 6 package NDCs
6 package NDCs map to RxCUI 197624 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 42794-0028-08 | 30 TABLET in 1 BOTTLE (42794-028-08) | Disulfiram | Sigmapharm Laboratories, LLC | 2021-11-01 |
| 42794-0029-08 | 30 TABLET in 1 BOTTLE (42794-029-08) | Disulfiram | Sigmapharm Laboratories, LLC | 2022-01-11 |
| 62135-0431-30 | 30 TABLET in 1 BOTTLE (62135-431-30) | Disulfiram | Chartwell RX, LLC | 2021-11-02 |
| 62135-0431-90 | 90 TABLET in 1 BOTTLE (62135-431-90) | Disulfiram | Chartwell RX, LLC | 2021-11-02 |
| 62135-0432-30 | 30 TABLET in 1 BOTTLE (62135-432-30) | Disulfiram | Chartwell RX, LLC | 2021-11-18 |
| 62135-0432-90 | 90 TABLET in 1 BOTTLE (62135-432-90) | Disulfiram | Chartwell RX, LLC | 2021-11-18 |
Observed labelers:
Chartwell RX, LLC (4) ·
Sigmapharm Laboratories, LLC (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.